Abstract: Cleidocranial dysplasia (CCD) and the RubinsteinTaybi syndrome (RTS) are two rare congenital syndromes that have many clinical signs in common. We present an 18-yearold-patient with untypical CCD expression who was misdiagnosed with RTS at the age of 2 years. An extensive craniofacial examination was carried out with respect to morphological and dental aspects. The molecular-genetic analysis of two underlying genes (CBFA1 and CBP) for CCD and RTS was performed using SSCP, direct sequencing and FISH.
Introduction
Cleidocranial dysplasia (CCD; MIM 119600) is an autosomal dominant disease with complete penetrance, but variable expressivity, first described by Marie and Sainton in 1898. The phenotype is characterized by general dysplastic bone formation manifested in typical anomalies in the skull: frontal bossing and a prognathic mandible, the pelvis and the thoracic region, hands and feet (1, 2) . Because of delayed skeletal development, commonly CCD patients are of short stature (3) . Characteristic disorders in the primary and secondary dentition are frequently reported (4) ( Tables 1 and 2) . Mutations in the core-binding factor a1 (CBFA1) gene (OMIM 600211) located on chromosome 6p21 have been shown to underlie CCD (5) .
The Rubinstein-Taybi syndrome (RTS) is an autosomal dominant disorder characterized by osseous manifestations such as retardation of growth, broad thumbs and big toes (MIM 180849 (6) (Tables 1 and 2 ). Ocular changes reported are down-slanting palpebral fissures, glaucoma, strabism and heavy or highly arched eyebrows (7) . RTS can result from microdeletions or point mutations in the CBP gene (OMIM 600140) on chromosome 16p13.3, which encodes the CREB-binding protein, a nuclear protein participating as a coactivator in cyclic AMP-regulated gene expression (8, 9) .
Although CCD and RTS are rare diseases with some similar symptoms, a correct diagnosis is essential for affected patients and their family members. Whereas in CCD life expectancy and quality of life are affected only marginally, patients suffering from RTS are mentally retarded and may have a shortened life span.
Subjects and methods

Case presentation
An 18-year-old patient came to our clinic for dental treatment. He had been diagnosed with RTS at the age of two. His skeletal growth and development were retarded. Because of the initial diagnosis, the parents had expected their son to be mentally retarded and possess a severely limited life span. The typical mental retardation, however, was not evident. No hereditary diseases were known in the family. A clinical examination was carried out with special emphasis on the craniofacial manifestations of CCD and RTS symptoms. To evaluate the facial soft tissue proportions, lateral photographs were taken under defined conditions. An intraoral and dental examination was performed. Lateral cephalometric and panoramic radiographs were taken to analyze the skeletal morphology of the skull and face and to characterize the dentition. Hand and feet radiographs were also taken (10). An ophthalmologic examination was carried out to diagnose any disorders in that area. Additionally, the body height was compared with the new Zurich standard centile charts (11).
Molecular-genetic analysis
In addition to the clinical examination, a moleculargenetic analysis of the CBFA1 gene and a cytogenetic analysis for the CBP gene were carried out. Informed, written consent was obtained for genetic testing and the study was approved by the university's ethical committee. RTS screening was performed as previously described (12, 13) . Metaphase slides were analyzed with fluorescent in-situ hybridization (FISH) using five cosmid clones spanning the complete CBP gene (14) . CCD screening was caused by through PCR-amplification with exon-specific primer pairs. Genomic DNA was isolated from venous blood. A combined approach using SSCP and ⁄ or automated sequencing was used to analyze the amplicons. Exon 2 was sequenced twice in both directions using two independent PCR amplifications. PCR and SSCP were performed as described previously (15) . The mutation was confirmed with a restriction enzyme digestion of the PCR fragment (restriction fragment length polymorphism).
Results
Our clinical examination revealed the following findings
Craniofacial findings
The evaluation of the frontal and en-face photographs revealed harmonious facial vertical proportions and no asymmetry. In the profile view the face was judged to be straight ⁄ concave. The nose and the chin were distinctly prominent (Fig. 1 ).
Intraoral findings
Extremely delayed dentition with multiple missing permanent teeth and persistent deciduous teeth. Cross bite in the molar region in combination with an open bite in the premolar region was apparent. A severe retrusion of upper and lower front teeth leading to restriction of biting and chewing. Teeth were shaped regularly and no structural anomalies such as talon cusps, typical of RTS, could be diagnosed (16) . 
Radiologic findings
On the panoramic X-ray, 24 retained regular and supernumerary teeth or buds could be seen in both jaws (Fig. 2) . The large number of retained deciduous teeth coincided with delayed eruption of the permanent teeth.
In the cephalometric radiographs, midfacial hypoplasia and a wide opened sella were diagnosed. Evaluations based on ÔAn Atlas of Craniofacial GrowthÕ data (17) showed an upward and forward displacement of the sella, most likely because of the reduced NSBa and SN measurements. Despite an enlarged vertical mandibular ramus, the posterior facial height stayed within the norms. This occurrence could be the result of the counteracting effect of the reduced development of the sphenoid bone in the vertical dimension (Table 3) .
Skeletal findings
Based on the Zurich growth centile diagram, patient's height of 170 cm at the age of 18 corresponded to the 20th centile. Defects of the lateral parts of the clavicles led to an increased shoulder mobility (Fig. 3) . Morphologic examination of hands and feet demonstrated widened thumbs and first toes (Fig. 4) .
Ophthalmologic findings
An iris cyst in the right eye, most likely of epithelial origin, was confirmed by B-scan ultrasound. No ocular disorders as described in RTS were found (18) .
Cytogenetic findings
Using FISH, we were able to show all cosmids present on both chromosomes 16. Thus, no microdeletion, associated with RTS, could be detected.
Molecular-genetic findings
A missense mutation was found at position 569 of the CBFA1 gene, which leads to the change R190Q (CGG fi CAG) in the predicted protein sequence. This mutation destroys one of the two recognition sites for the restriction enzyme HpaII. Segregation of this marker within the family was confirmed (Fig. 5) .
Additional 100 control chromosomes were tested for the occurrence of this mutation (data not shown).
Discussion
As CCD and RTS are both rare diseases (approximately 1000 cases of both disorders are known to exist) and because of their widespread manifestations involve several medical fields for both diagnosis and therapy, reliable statistical data hardly exists. Findings like the highly prominent beaked nose, the profile concavity, or the broad toes are typical for RTS [consequently, also referred to as ÔBroad Thumb-Hallux SyndromeÕ (19) ], but unusual in CCD. It is likely that these clinical signs, in combination with a reduced body height, led to the incorrect diagnosis of RTS, which we were able to rule out. The conspicuous shoulder movements in addition to the oral findings (Tables 1 and 2 ) led us to the genetically confirmed primary diagnosis of CCD, although both findings are not routinely expressed in mild cases. The iris cyst was possibly a chance finding, as it is not described in either syndrome.
The only currently available molecular-diagnostic technique for the CBP-gene is screening with FISH. The incidence of clinically diagnosed individuals with RTS is about 8% (20) . The missense mutation R190Q was found in the runt domain of CBFA1, which is responsible for DNA binding and heterodimerization with the b-subunit. Levanon et al. (21) showed that R190 belongs to the part of the runt domain that forms one of the DNA binding loops. Two arginines in close vicinity of the mutated R190 interact with two guanine bases of the core motif PyGPyGGT (Py ¼ C or T). Zhou et al. (22) first described this mutation in a CCDpatient characterized by a delayed fontanel closure and hypoplastic clavicles, and showed that the mutation R190Q completely abolished binding to the consensus CBFA1-binding sequence.
Current screening protocols for the CBFA1-mutation findings include only the protein coding areas, exons 0-8. Possible mutations in the regulatory regions in the two promoters are currently not diagnosable. In our opinion, this is the reason for the reported low mutations finding rate of 33-50% (12) . Furthermore, this means that if the present case had revealed no mutation in the CBFA1 gene, it would still have been a CCD case.
It seems critically important for the clinicians to re-evaluate patients and question previous diagnosis, especially when the ramifications of an incorrect diagnosis can be devastating to the family. Since the diagnosis of rare congenital diseases, such as CCD and RTS is currently still based on the clinical phenomenology of small groups or single cases, molecular-genetic analysis now gives us the opportunity for its confirmation within the genotype. Indeed, as the comparisons of clinical findings with molecular-genetic data become possible, the examination of the phenotypic expression of nominated genes could be more exacting. Eventually, clinical symptomatology described in the literature will have to be revised to include molecular-biological diagnostics. It should keep in mind, however, even if a correlation could be found between a particular gene defect to a certain phenotype, we are still a long way away from understanding the interactive control mechanism of the coded protein(s) during embryogenesis. The risk exists to associate -in a false-positive mannera certain phenomenology with a certain gene. We found a missense mutation in the CBFA1 gene, which destroys one of two recognition sites for the restriction enzyme HpaII. In order to confirm the segregation of this marker within the family, the corresponding gene fragment was amplified with PCR. The fragments of all family members were digested with HpaII and the reaction products were separated by size on an agarose gel. Because of the loss of the recognition site the heterozygous patient shows an additional fragment of 168 bp length. His father, mother, and a non-affected control show the unmodified restriction pattern.
